|






























| |
|
 |
MYCOLOGY - CHAPTER SIX
DIMORPHIC FUNGI
|
|
WEB RESOURCES
CDC-Blastomycosis |
A. BLASTOMYCOSIS (Blastomyces
dermatitidis)
Most of the systemic
fungi have a specific niche in nature where they are commonly found. Blastomyces
dermatitidis survives in soil that contains organic debris (rotting wood, animal
droppings, plant material) and infects people collecting firewood, tearing down
old buildings or engaged in other outdoor activities which disrupt the soil. In
addition to an ecological niche, most fungi that cause systemic infections have
a limited geographic distribution where they occur most frequently.
Blastomycosis occurs in eastern North America (figure 6) and Africa. The vast majority of
patients with blastomycosis in South Carolina are infected in the northern
part of the state, above the Fall Line (Augusta, GA, Aiken, Columbia, Cheraw,
Raleigh, NC). |
Figure 1.
Nodular skin lesions of
blastomycosis, one of which is a bullous lesion on top of a nodule.
CDC |
| |
Figure 2.
Histopathology of blastomycosis of skin. Budding cell of
Blastomyces dermatitidis surrounded by
neutrophils. Multiple nuclei are visible.
CDC |
Figure 3.
Smear from foot lesion of blastomycosis showing Blastomyces dermatitidis yeast cell undergoing
broad-base budding.
ASCP/Atlas of Clinical Mycology II
/ CDC |
Figure 4.
Histopathology of
blastomycosis. Yeast cell of Blastomyces dermatitidis undergoing broad-base budding. Methenamine silver stain. African case.
CDC |
Figure 5.
Histopathology of blastomycosis, lung of wolf. Yeast cells of
Blastomyces
dermatitidis. FA stain.
CDC/Dr. Leo Kaufman |
Figure 6.
Map of eastern United States and Canada showing distribution of reported cases of blastomycosis. CDC |
Blastomycosis is a chronic granulomatous disease which means that
it progresses slowly. Although the pulmonary and skin (figure 1) involvement is the most
common, B. dermatitidis frequently affects bone, prostate and other
organs. More frequently blastomycosis presents as a cutaneous or a respiratory
disease. The cutaneous lesions may be primary (usually self-limiting) or
secondary (a manifestation of systemic disease). The patient who presents with a
complaint of respiratory symptoms will frequently remark about loss of appetite,
loss of weight, fever, productive cough, and night sweats. While these symptoms
resemble those of TB, it is not this disease. The X-ray shows obvious pulmonary disease. To
make the specific diagnosis, the physician must be aware of blastomycosis. Sputum
sent to the lab for "culture" will not grow the organism. The lab must
be alerted to look for fungal organisms or to look specifically for blastomyces.
Some patients have a sub-clinical or "flu-like" response to infection.
B. dermatitidis can frequently be demonstrated in a KOH preparation of
pus from a skin lesion. A typical cutaneous lesion shows central healing with
microabscesses at the periphery. A pus specimen may be obtained by nicking the
top of a microabscess with a scalpel, obtaining the purulent material and making
the diagnosis in 5 min. by microscopic examination with KOH. This organism has a
characteristic appearance of a double contoured wall with a single bud on a wide
base (figures 2 - 5). There are no specific virulence factors for B. dermatitidis. Laboratory
specimens depend on the manifestation of the disease: If there are skin lesions,
send skin scrapings or pus. If there is pulmonary involvement, send sputum.
Other specimens include biopsy material and urine. Occasionally, the organism
can be isolated from urine as it often infects the prostate.
Mycology
If you
request a fungus culture from the microbiology lab, they will incubate the
cultures at 37 degrees C and at 25 degrees C because most of the significant pathogenic fungi
are dimorphic.
A culture of B. dermatitidis takes
2 to 3 weeks to grow at 25 degrees C. It appears as a white, cottony mold
(mycelium) on Sabouraud dextrose agar. Most specimens for fungus culture are
plated on Sabouraud's dextrose agar. Microscopically, the mycelia and the
fruiting bodies are evident. However, the mold cannot be identified by its
fruiting bodies. The fruiting bodies are called microconidia, but they are not
distinctive. Other fungal saprophytes and pathogens have similar conidia. At 37
degrees C the yeast form grows in about 7-10 days. It appears as a buttery-like, soft
colony with a tan color. Microscopically, we see the typical yeast form of a
thick wall and a single bud with a WIDE BASE. This wide base is characteristic
of B. dermatitidis, and it is important to be able to recognize this. The
cells are 12-15 microns in diameter. The yeast will convert to the mycelial form
when incubated at 25 degrees C, taking from 3 to 4 days up to a few weeks. Similarly,
the mycelial growth can be converted to yeast form when incubated at 37 degrees
C.In the
past, the only way to identify the dimorphic fungi was to convert from one form
to the other, but now it is possible to take the mycelial growth (which is the
easiest to grow), and confirm the isolate with a DNA probe in a matter of hours.
Histopathology
B. dermatitidis produces
both a granulomatous and suppurative tissue reaction
Serology
There are three
serological tests used for blastomycosis:
1. Immunodiffusion test (precipitin). This
requires 2 to 3 weeks to become positive. This test is positive in about 80% of
the patients with blastomycosis. When it is positive, there is close to 100%
specificity.
2. Complement fixation (CF) test. This
test requires 2 to 3 months after the onset of disease to develop detectable
antibody. Besides the long delay before there is measurable antibody, another
disadvantage of the C-F is that it cross reacts with other fungal infections (coccidioidomycosis
and histoplasmosis). The advantage is that it is a quantitative test. The
physician can follow the patient's response to the disease by monitoring the
antibody titer.
3. Enzyme Immunoassay (EIA). The latter
test has met with mixed acceptance by mycologists. However it is easy to perform
and antibody is detected early in the disease process.
Amphotericin B remains is the drug of
choice (DOC) although it is very toxic and must be administered intravenously
for several weeks. Ketoconazole is also being used in mild cases.
|
| |
B. HISTOPLASMOSIS (Histoplasma
capsulatum)
Histoplasmosis is a systemic disease, mostly of the
reticuloendothelial system, manifesting itself in the bone marrow, lungs (figure
12-17), liver,
and the spleen. In fact, hepatosplenomegaly is the primary sign in children,
while in adults, histoplasmosis more commonly appears as pulmonary disease. This
is one of the most common fungal infections, occurring frequently in South
Carolina,
particularly the northwestern portion of the state. The ecological niche of H.
capsulatum is in blackbird roosts, chicken houses and bat guano. Typically,
a patient will have spread chicken manure around his garden and 3 weeks later
will develop pulmonary infection. There have been several outbreaks in South
Carolina
where workers have cleared canebrakes which served as blackbird roosts with
bulldozers. All who were exposed, workers and bystanders, contracted
histoplasmosis. Histoplasmosis is a significant occupational disease in bat
caves in Mexico when workers harvest the guano for fertilizer. In the endemic
area the majority of patients who develop histoplasmosis (95%) are asymptomatic.
The diagnosis is made from their history, serologic testing or skin test. In the
patients who are clinically ill, histoplasmosis generally occurs in one of three
forms: acute pulmonary, chronic pulmonary or disseminated. There is generally
complete recovery from the acute pulmonary form (another "flu-like" illness).
However, if untreated, the disseminated form of disease is usually fatal.
Patients will first notice shortness of breath and a cough which becomes
productive. The sputum may be purulent or bloody. Patients will become anorexic
and lose weight. They have night sweats. This again sounds like tuberculosis,
and the lung x- ray also looks like tuberculosis, but today radiologists can
distinguish between these diseases on the chest film (histoplasmosis usually
appears as bilateral interstitial infiltrates). Histoplasmosis is prevalent
primarily in the eastern U.S. In S.C., a histoplasmin skin test survey of
lifetime, one county residents, white males, 17 to 21 years old, was performed
on Navy recruits. The greatest number of positive skin tests appeared in the
northwestern part of the state. A similar study of medical students conducted at
Medical University of South Carolina, about 25 years ago, bore the same distribution (Goodman and Ever, J.S.C.M.A.
67:53-55, 1971).The skin test is NOT used for diagnostic purposes, because it
interferes with serological tests. Skin tests are used for epidemiological
surveys.
Clinical specimens sent to the lab depend
on the presentation of the disease: Sputum or Bronchial alveolar lavage, if it
is
pulmonary disease, or Biopsy material from the diseased organ. Bone marrow is an
excellent source of the fungus, which tends to grow in the reticulo-endothelial
system. Peripheral blood is also a source of visualizing the organism
histologically. The yeast (figures 7-11) is usually found in monocytes or in PMN's. Many times
an astute medical technologist performing a white blood cell count will be the
first one to make the diagnosis of histoplasmosis. In peripheral blood, H.
capsulatum appears as a small yeast about 5-6 microns in diameter. (Blastomyces
is 12 to 15 microns). Gastric washings are also a source of H. capsulatum
as people with pulmonary disease produce sputum and frequently swallow their
sputum.
Mycology
When it is grown on Sabouraud
dextrose agar at 25 degrees C, it appears as a white, cottony mycelium after 2 to 3
weeks. As the colony ages, it becomes tan. In the mold form, Histoplasma has a
very distinct spore called a tuberculate macroconidium. The tubercles are
diagnostic, however there are some non-pathogens which appear similar. A medical
mycologist will be able to distinguish them. Grown at 37 degrees, C the yeast form
appears. It is a white to tan colony. The yeast cell is 5-6 microns in diameter
and slightly oval in shape. This is not diagnostic. To confirm the diagnosis,
one must convert the organism from yeast to mycelium or vice-versa or use the
DNA probe.
Serology for histoplasmosis is a little
more complicated than for other mycoses, but it provides more information than
blastomycosis serology.
There are 4 tests:
1. Latex agglutination
2. Complement Fixation
3. Immunodiffusion
4. EIA
Each of these serological tests has
different characteristics that make them useful. The latex agglutination test is
a very simple test involving agglutination in a test tube. The Ab is fairly
specific and rises early in the disease (in the first 2 weeks), and disappears
in about 3 months. The complement fixation test is like the one for
blastomycosis,
except there are 2 antigens, one to the yeast form of the organism and the other
to the mycelial form. Some patients react to one form and not the other, while
some individuals react to both. The reason for the different responses is not
clear. One disadvantage is that complement fixing antibody develops late in the
disease, about 2 to 3 months after onset. A second disadvantage is that it cross
reacts with other mycotic infections. An advantage of the C-F test is that it is
quantitative, so the physician can follow the course of the disease by observing
the titer of several samples. The interpretation of the immunodiffusion test is a
little more complicated than with blastomycosis because there are two bands
which may appear. An H band indicates active disease and will appear in 2 to 3
weeks. An M band can indicate past or present disease, or result from a skin
test. This is one reason why skin tests are not used for diagnosis because they
can interfere with other tests. Skin tests will also affect the complement
fixation test.
Recently, a radioimmunoassay for
histoplasma polysaccharide antigen has been developed. This is a proprietary
test so the evaluation of the results have been questioned. The drug of choice
(DOC) is amphotericin B, with all its side effects. Itraconazole is now also
being used.
|
|
WEB RESOURCES
CDC-Histoplasmosis |
Figure 7.
Histoplasmosis
© Bristol Biomedical Image Archive. Used
with permission |
Figure 8.
Histopathology of histoplasmosis showing yeast forms of
Histoplasma
capsulatum. This fungus
shows thermal dimorphism: mold form at 25°C and yeast form at 37°C.
CDC
© Bristol Biomedical Image Archive. Used
with permission |
Figure 9.
Histiocyte containing numerous yeast cells of Histoplasma
capsulatum. Dr. D. T. McClenan
/ CDC |
Figure 10.
Histopathology of histoplasmosis in open lung biopsy. FA stain reveals numerous yeast cells of
Histoplasma
capsulatum.
CDC/Dr. Leo Kaufman, Maxine Jalbert
lek1@cdc.gov |
Figure 11.
Methenamine silver stain reveals Histoplasma capsulatum fungi.
CDC/Dr. Edwin P. Ewing, Jr. epe1@cdc.gov |
Figure 12.
Gross pathology specimen of lung showing cut surface of fibrocaseous nodule due to Histoplasma
capsulatum.
ASCP Atlas of Clinical Mycology II
/ CDC |
Figure 13.
Chest radiograph showing miliary densities in both lung fields plus thin-walled cavity with fluid level. Histoplasmosis.
ASCP Atlas of Clinical Mycology II /CDC |
Figure 15.
Chest radiograph showing single pulmonary nodule of histoplasmosis.
Case 49-03. Mass Gen Hosp Case Records.
CDC |
Figure 16.
Computed tomography scan of lungs showing classic snowstorm appearance of acute histoplasmosis CDC |
Figure 17.
Computed tomography scan showing single pulmonary nodule of histoplasmosis. Case 49-01. Mass Gen Hosp Case Records.
CDC |
Figure 18.
Map of United States showing geographic variation in the prevalence of coccidioidin sensitivity in young adults
CDC |
C. COCCIDIOIDOMYCOSIS (Coccidioides
immitis)
Coccidioidomycosis is primarily a pulmonary disease. About 60 % of
the infections in the endemic area are asymptomatic. About 25 % suffer a
"flu-like"
illness and recover without therapy. This disease exhibits the typical symptoms
of a pulmonary fungal disease: anorexia, weight loss, cough, hemoptysis, and
resembles TB. CNS infection with C. immitis is more common while it is
less frequent with the other fungal diseases. The ecological niche of C.
immitis is the Sonoran desert, which includes the deserts of the Southwest
(California, Arizona, New Mexico and Texas) and northern Mexico (figure 18). It is also
found in small foci in Central and South America.
Desert soil, pottery,
archaeological middens, cotton, and rodent burrows all harbor C. immitis.
C. immitis is a dimorphic fungus with 2 life cycles. The organism follows
the SAPROPHYTIC cycle in the soil and the PARASITIC cycle in man or animals. The
saprophytic cycle starts in the soil with spores (arthroconidia) that develop
into mycelium. The mycelium then matures and forms alternating spores within
itself. The arthroconidia are then released, and germinate back into mycelia.
The parasitic cycle involves the inhalation of the arthroconidia by animals
which then form spherules filled with endospores. The ambient temperature and
availability of oxygen appear to govern the pathway The organism can be carried
by the wind and therefore spread hundreds of miles in storms so the distribution
is quite wide. In 1978, cases were seen in Sacramento 500 miles north of the
endemic area, from a dust storm in Southern California. The spores of the
organism are readily airborne. The cases that occur in South Carolina are
usually in patients who have visited an endemic area and brought back pottery,
or blankets purchase from a dusty roadside stand, or in Navy and Air Force
personnel who were exposed when they were stationed in the endemic area. The
disease manifests itself after they are transferred to a base in South Carolina.
A few interesting cases occurred in cotton mills in Burlington and Charlotte,
N.C. The cotton, grown in the desert of the Southwest, was contaminated with the
fungus and the mill workers inhaled the spores while handling the raw cotton and
developed coccidioidomycosis.
|
Figure 19.
Smear of exudate showing spherules of Coccidioides
immitis. Experimental infection of mouse with soil sample.
CDC |
Clinical Specimens
Clinical specimens
include sputum, pus from skin lesions, gastric washings, CSF, and biopsy
material from skin lesions.
Mycology
C. immitis is a dimorphic fungus (figure 19-23).
Cultured on Sabouraud's agar at 25 degrees C it grows as a mold in 2 to 3 weeks.
Characteristically, the mycelia develop arthroconidia. ("By their fruits ye
shall know them"). It is a barrel-shaped (smaller at the edges, wider at
the middle) asexual spore. Typically, the arthroconidia alternate with non
spore-forming cells in the mycelium. When grown in vitro at 37 degrees C, there is
no yeast form!! C. immitis is a dimorphic fungus; in vivo, (pus or
tissue) one sees the pathogenic or invasive form B which is a spherule. The
organism develops into spherules (30-60 microns) that are filled with endospores
which are 3 to 5 microns in diameter (see figure above). A spherule will develop endospores within,
then break apart, releasing the endospores. This is the tissue form seen in pus
or histological sections: spherules and loose endospores. They can also be seen
in a KOH preparation of sputum. It is pathognomonic for coccidioidomycosis.
|
| |
Histopathology
The inflammatory reaction
is both purulent and granulomatous. Recently released endospores incite a
polymorphonuclear response. As the endospores mature into spherules, the acute
reaction is replaced by lymphocytes, plasma cells, epithelioid cells and giant
cells.
|
Figure 20.
Histopathology of
coccidioidomycosis, retroperitoneal area.
Coccidioides immitis fungi are visible within
granuloma.
CDC/Dr. Edwin P. Ewing, Jr.
epe1@cdc.gov |
Figure 21.
Histopathology of coccidioidomycosis of lung. Mature spherule
with endospores of Coccidioides
immitis, intense infiltrate of neutrophils.
CDC/Dr. Lucille K. Georg |
Figure 22.
Histopathology of
coccidioidomycosis. Spherule of Coccidioides immitis with
endospores.
Mercy Hosp Toledo OH/Brian J. Harrington |
Figure 23.
Histopathology of coccidioidomycosis of lung showing spherule
with endospores of Coccidioides
immitis. FA stain. Endospores, not spherule wall, are stained.
CDC |
Figure 24.
Erythema nodosum lesions on skin of back due to
hypersensitivity to antigens of Coccidioides immitis
CDC/Dr. Lucille K. Georg |
Figure 24.
Immune responses during
coccidioidomycosis. Line graph showing immunologists' concept of the interplay between humoral and cell-mediated immune responses during
coccidioidomycosis. TX State Chest Hosp/Dr. Rebecca A. Cox |
Serology
There are four tests for diagnosis:
1. Complement-Fixation
2. Slide agglutination
3. Immunodiffusion
4. EIAC-F antibody is slow to rise and
develop in about 1 month. This test is excellent for coccidioidomycosis because
it is quantitative. However, these antibodies cross-react with some other fungi
(Blastomyces and Histoplasma). The C-F test is also a PROGNOSTIC test. If the
titer keeps rising, then the patient is responding poorly and the course may be
fatal. If the C-F titer is dropping then the prognosis for that patient is
favorable. A titer of greater than 1:128 usually indicates extensive
dissemination. Life-long immunity usually follows infection with C. immitis. There
is a much greater mortality rate in dark-skinned people (Mexicans, Filipinos,
and Blacks). They are 25 times more likely to develop progressive disease and
death. The reason for this is obscure.
Amphotericin B, fluconazole and
itraconazole are the drugs of choice.
|
| |
D. PARACOCCIDIOIDOMYCOSIS (Paracoccidioides
brasiliensis) |
Figure
25.
Paracoccidioidomycosis: Mouth Mucosa
in man © Bristol Biomedical Image Archive. Used
with permission
Figure 26.
Tongue lesion of paracoccidioidomycosis. CDC/Dr. Lucille K. Georg |
This is a chronic granulomatous disease of mucous membranes,
skin, and pulmonary system. This disease occurs from the middle of Mexico (North
America) to Central and South America. Most cases are reported from Brazil. The
ecological niche of this organism is probably the soil. A common triad of
symptoms that are seen in Latin America is pulmonary lesions, edentulous mouth
(figure 25 and 26),
and cervical lymphadenopathy. Prior to the recognition of this disease, patients
in Latin America with paracoccidioidomycosis were often sent to TB sanitariums,
just as patients with histoplasmosis were in the U.S. The organisms invade the
mucous membranes of the mouth causing the teeth to fall out. White plaques are
also found in the buccal mucosa, and this along with the triad are now used to
clinically differentiate between TB and. This disease has a long latency period.
10-20 years may pass between infection and manifestation of the infection in the
non-endemic areas of the world. Typically, a case of paracoccidioidomycosis seen
in the U.S. occurs in someone who worked in South America for some period of
time and then they return to the U.S. and years later, develop this disease. The
patient does not realize the importance of this past history. Almost all
diagnoses of fungal diseases depend upon careful questioning and a probing
history.The clinical material which should be sent to the lab for examination is
sputum, biopsy material, pus, and crust from the lesions. Examination of sputum
or crust from one of the lesions with KOH reveals a yeast because this is a
dimorphic fungus. In contrast to the other yeasts, particularly Blastomyces,
Paracoccidioides has multiple buds, a thin cell wall, and a narrow base. At 25
degrees C, the colony is a dense, white mycelium (figure 27), not loose and cottony like the others.
On Sabouraud's agar (figure 28) it takes 2-3 weeks to grow. When cultured at 37 degrees C, it is
slow growing with a white-tan, thick colony. Microscopically, these yeasts
appear as described above ranging in size from 5 to 15 microns.
Histopathology
Histologically, one sees
multiple buds forming a "Captain's wheel." This is diagnostic of
paracoccidioidomycosis. In this case, the mother cell is 40-50 microns in
diameter and the buds are 2-5 microns in size (figure 29-31).
Serology
The best serological test for
paracoccidioidomycosis is the immunodiffusion test. It is better than 99%
specific and almost 85% sensitive.
Therapy
The D.O.C. is amphotericin B.
Sulphonamide-trimethoprim and ketoconazole have also been used. Presently
Itraconazole appear to provide the best recovery.
|
Figure 27.
Lowenstein-Jensen slant culture of the fungus Paracoccidioides
brasiliensis grown at 37°C. CDC/Dr. William
Kaplan |
Figure 28.
Sabouraud dextrose agar slant culture of the fungus Paracoccidioides
brasiliensis grown at 37°C CDC/Dr. William
Kaplan |
Figure 29.
Histopathology of
paracoccidioidomycosis. Budding cell of
Paracoccidioides
brasiliensis. Methenamine silver stain.
CDC |
Figure 30.
Histopathology of
paracoccidioidomycosis, skin. Budding cell of
Paracoccidioides brasiliensis within multinucleated giant cell.
CDC/Dr. Lucille K. Georg |
Figure 31.
Histopathology of
paracoccidioidomycosis. Budding cells of
Paracoccidioides brasiliensis. Methenamine silver stain.
CDC/Dr. Lucille K. Georg |
Figure 32.
This patient presented with sporotrichosis affecting the skin of the
thumb.
CDC
Figure 33.
conidiophores and conidia of the fungus Sporothrix schenckii
CDC/Dr. Libero Ajello
Figure 34.
SABHI agar plate culture of Sporothrix schenckii grown at 20°C
CDC/Dr.
William Kaplan
|
E. SPOROTRICHOSIS (Sporothrix schenckii)
Sporotrichosis is usually a chronic
infection of the cutaneous or subcutaneous tissue which tends to suppurate,
ulcerate and drain. In recent years, a pulmonary disease has been seen more
frequently. Occasionally, infection with S. schenckii may result in a
mycetoma. Sporotrichosis is caused by another dimorphic fungus. The infection is
also known as "rose growers disease." The ecologic niche for this
organism is rose thorns, sphagnum moss, timbers and soil. A study on the
occupational distribution of sporotrichosis showed that forest employees
accounted for 17% of the cases, gardeners and florists, 10%; and other
soil-related occupations another 16%. Sporotrichosis occurs worldwide. Every
aspect of this disease (clinical, pathology, mycology, ecology) was investigated
during an epidemic of 3,000 patients in a gold mine in South Africa during the
1940's. Patient history is very important in this disease also. It is often seen
in gardeners and begins with a thorn prick on the thumb (figure 32). A pustule develops and
ulcerates. It infects the lymphatic system and then the disease progresses up
the arm with ulceration (figure 37), abscess formation, break down of the abscess with large
amounts of pus followed by healing. Progression usually stops at the axilla.
Clinical material to be sent to the lab may be pus, biopsy material, or sputum
from pulmonary patients. The yeast form of this fungus in tissue or in culture,
can be round (6 - 8 um) or fusiform. The fusiform shape is not the usual
form but if a cigar-shaped yeast is observed in tissue, it is usually diagnostic
of sporotrichosis. S. schenckii does not stain with the usual
histopathological stains. If sporotrichosis is suspected, the pathologist must
be informed so he can use special stains. Histologically asteroid bodies, a
tissue reaction (also known as Splendori reaction) may be seen around the yeast
cell. At 25 degrees C, this colony is white-cream and very membranous (figure 34
and 35), but as it ages for
2-3 weeks it becomes black and leathery (figure 36). Microscopically, the mycelium is
branching, septate and very delicate, 2-3 um in diameter (figure 33). The pyriform conidia,
2-4 um form a typical arrangement in groups at the end of a conidiophore
called "daisies" (figure 33). Serologic tests are not commercially available. The
drug of choice for the cutaneous form is saturated iodides (e.g., potassium
iodide) administered orally. The patient begins with 2-3 drops, 3-4/days until
tolerance to the drug is built up, then the dose is increased. Potassium iodide
may interact with the host immune system. For the systemic form the drug of
choice is itraconazole or amphotericin B. |
|
WEB RESOURCES
CDC-Sporotrichosis |
Figure 35.
SABHI agar slant culture of the fungus Sporothrix schenckii grown
at 37 degrees
CDC/Dr. William Kaplan |
Figure 36.
Sabouraud's dextrose agar plate culture is growing the fungus Sporothrix
schenckii
CDC/Dr.
Lucille K. Georg |
Figure 37.
This patient’s arm shows the effects of the fungal disease
sporotrichosis,
caused by the fungus Sporothrix schenckii
CDC/Dr.
Lucille K. Georg |
|
|
| |
|